PD-1 is mainly expressed on activated T cells, but also on NK cells, called “PD-1+NK cells” accounting for 25% of NK cells, whose expression is increased in a variety of cancers indicating a poor prognosis (47, 48). This evidence concerns the gene PDCD1 and cancer.